Medical Doctor Program year 2024 Reported 2019–2024 Source: CMS Open Payments, 2026 publication

Adly Thebaud

Psychiatry Orange City, FL Medical Doctor

NPI 1629049770 CMS profile 163845

2725 Rebecca Ln Ste 107, Orange City, FL 32763

Open in the dashboard

General payments

$3,415

20 records reported · program years 2019–2024

Research payments

$205,827

Paid to them · 49 records reported · program years 2019–2024

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$1,531,944 paid to institutions, not to them · program years 2019–2025

Through program year 2024, Adly Thebaud of Orange City, FL is reported in the CMS Open Payments database as having received $3,415 across 20 general payments and $205,827 in research payments paid to them. Separately, studies naming them as principal investigator received $1,531,944 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 98th percentile of Psychiatry profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $24 1
2023 General $1,779 14
2023 Research $300 1
2022 Research $371 1
2021 Research $9,009 2
2020 Research $118,314 2
2019 General $1,612 5
2019 Research $77,833 43

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Adly Thebaud
  • Psychiatry median
  • Middle half of Psychiatry
  • National median

In program year 2025, general payments to Adly Thebaud were reported at $0. Among 14,155 Psychiatry profiles paid that year, the median was $180 and the middle half received between $58 and $685.

Show as a table
Year Adly Thebaud Psychiatry median Middle half National median
2019 $1,612 $184 $59–$605 $163
2020 $0 $119 $36–$372 $114
2021 $0 $143 $43–$576 $132
2022 $0 $153 $50–$590 $149
2023 $1,779 $170 $56–$651 $160
2024 $24 $179 $57–$673 $164
2025 $0 $180 $58–$685 $169

Breakdown

Who paid General payments · program years 2019–2024
  1. Neurocrine Biosciences, Inc. $1,779 14 payments
  2. Pfizer Inc. $1,612 5 payments
  3. AbbVie, Inc. $24 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2024
  1. Travel and Lodging $2,279 9 payments
  2. Food and Beverage $1,136 11 payments
Products named General payments · program years 2019–2024
  1. GEODON $1,612 5 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2024
  1. Otsuka Pharmaceutical Development & Commercialization, Inc. $127,925 10 payments
  2. Arbor Pharmaceuticals, Inc. $60,440 6 payments
  3. Teva Pharmaceuticals USA, Inc. $7,050 7 payments
  4. Allergan Inc. $6,675 5 payments
  5. Supernus Pharmaceuticals, Inc. $2,366 18 payments
  6. Eli Lilly and Company $1,371 3 payments

Billing to Medicare

Part B · data year 2024 · 3 billing codes

Paid by Medicare

$13,912

Medicare's payments for the services billed

Medicare patients

41

Average age 68

Services billed

164

27 women, 14 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Depression 75%
Arthritis 71%
Diabetes 54%
COPD 32%
Chronic kidney disease 29%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

69 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Psychiatry in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record